Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Colorectal Cancer
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Enrollment
- 800
- Locations
- 1
- Primary Endpoint
- Colorectal Cancer Screening Completion
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
This is a 3-arm randomized trial aimed at increasing rates of participation in colorectal cancer (CRC) screening by outreach to patients' homes using choice architecture informed by behavioral science principles.
Detailed Description
The investigators will evaluate the effectiveness of mailed outreach with choice between colonoscopy and FIT, and FIT alone, as compared to colonoscopy alone in increasing CRC screening rates.
Investigators
Shivan Mehta
Principal Investigator
Abramson Cancer Center at Penn Medicine
Eligibility Criteria
Inclusion Criteria
- •At least 1 visit with CHDC in the past 2 years
- •Not up to date on CRC screening (no evidence of colonoscopy in the last 10 years, sigmoidoscopy in the last 5 years, or stool testing in the past 12 months)
Exclusion Criteria
- •History of CRC or polyps
- •Significant family history of CRC
- •History of Inflammatory Bowel Disease or Ulcerative Colitis
- •History of colectomy
- •History of metastatic cancer
- •Current use of Medication Assisted Therapy (MAT)
Outcomes
Primary Outcomes
Colorectal Cancer Screening Completion
Time Frame: 6 months from initial outreach
Screening completion rate in arm 2 (Choice) to arm 1 (Colonoscopy only) and arm 3 (FIT only) separately.
Secondary Outcomes
- Choice of Colorectal Cancer Screening Test(6 months from initial outreach)